Loading...
Rapid Micro Biosystems, Inc.
RPID•NASDAQ
Healthcare
Medical - Devices
$4.08
$-0.26(-5.99%)
Rapid Micro Biosystems, Inc. (RPID) Financial Performance & Income Statement Overview
Review Rapid Micro Biosystems, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
24.57%
↑ 24.57%
Operating Income Growth
11.75%
↑ 11.75%
Net Income Growth
10.63%
↑ 10.63%
Operating Cash Flow Growth
2.06%
↑ 2.06%
Operating Margin
-159.58%
↓ 159.58%
Gross Margin
12.11%
↑ 12.11%
Net Profit Margin
-151.22%
↓ 151.22%
ROE
-56.07%
↓ 56.07%
ROIC
-67.16%
↓ 67.16%
Rapid Micro Biosystems, Inc. (RPID) Income Statement & Financial Overview
Review Rapid Micro Biosystems, Inc.'s (RPID) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $8.22M | $7.60M | $6.62M | $5.61M |
| Cost of Revenue | $7.24M | $6.98M | $6.81M | $7.13M |
| Gross Profit | $981000.00 | $622000.00 | -$189000.00 | -$1.52M |
| Gross Profit Ratio | $0.12 | $0.08 | -$0.03 | -$0.27 |
| R&D Expenses | $3.40M | $3.61M | $3.74M | $3.84M |
| SG&A Expenses | $7.81M | $9.05M | $9.45M | $8.91M |
| Operating Expenses | $11.21M | $12.66M | $13.19M | $12.75M |
| Total Costs & Expenses | $18.45M | $19.64M | $20.00M | $19.88M |
| Interest Income | $575000.00 | $768000.00 | $838000.00 | $983000.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $869000.00 | $729000.00 | $828000.00 | $1.11M |
| EBITDA | -$9.36M | -$11.31M | -$12.55M | -$13.57M |
| EBITDA Ratio | -$1.14 | -$1.49 | -$1.90 | -$2.42 |
| Operating Income | -$10.23M | -$12.04M | -$13.38M | -$14.27M |
| Operating Income Ratio | -$1.24 | -$1.58 | -$2.02 | -$2.54 |
| Other Income/Expenses (Net) | $554000.00 | $729000.00 | $815000.00 | $954000.00 |
| Income Before Tax | -$9.68M | -$11.31M | -$12.56M | -$13.32M |
| Income Before Tax Ratio | -$1.18 | -$1.49 | -$1.90 | -$2.37 |
| Income Tax Expense | -$9000.00 | $13000.00 | $15000.00 | $3000.00 |
| Net Income | -$9.67M | -$11.32M | -$12.58M | -$13.32M |
| Net Income Ratio | -$1.18 | -$1.49 | -$1.90 | -$2.37 |
| EPS | -$0.22 | -$0.26 | -$0.29 | -$0.31 |
| Diluted EPS | -$0.22 | -$0.26 | -$0.29 | -$0.31 |
| Weighted Avg Shares Outstanding | $43.77M | $43.67M | $43.62M | $43.25M |
| Weighted Avg Shares Outstanding (Diluted) | $43.77M | $43.67M | $43.62M | $43.25M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan